STDs During the COVID-19 Pandemic

In the wake of the arrival of COVID-19 in the United States, health departments, clinics, drug manufacturers, and hospitals around the country have shifted their resources to meet the virus on the frontlines. However, this massive shift in priorities is not without collateral damage in other areas of the healthcare system. There has been a notable decrease in available resources for sexually transmitted disease (STD) testing and treatment.